Discover
TRDA
Entrada Therapeutics, Inc.
7.59
2 x 5.44
2 x 9.44
bid
ask
+
0.23
3.12%
2 @ 04:00 PM
7.51 -0.08 (1.05%)
| Ytd | -26.17% | |
| 1y | 6.75% |
7.32
day range
7.71
4.93
52 week range
16.45
| Open | 7.35 | Prev Close | 7.36 | Low | 7.32 | High | 7.71 | Mkt Cap | 294.65M |
| Vol | 272.56K | Avg Vol | 391.14K | EPS | -4.00 | P/E | N/A | Forward P/E | -5.54 |
| Beta | -0.27 | Short Ratio | 11.43 | Inst. Own | 80.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 8.46 | 200-d Avg | 9.53 | 1yr Est | 26.43 |
TRDA News
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
Guggenheim Maintains Buy on Entrada Therapeutics, Lowers Price Target to $17
Guggenheim analyst Debjit Chattopadhyay maintains Entrada Therapeutics (NASDAQ:TRDA) with a Buy a
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
Entrada Advances Duchenne Muscular Dystrophy Drug to Higher Dose Cohort, Safety Review Clears Next S
Entrada Therapeutics, Inc. (NASDAQ:TRDA) today announced that an independent Data Monitoring Committ